Published in Brain on September 01, 1977
Assessment of extrapyramidal disorders. Br J Clin Pharmacol (1981) 1.86
Action myoclonus after cerebral hypoxia: treatment with clonazepam. J R Soc Med (1992) 1.25
The restless legs syndrome. Postgrad Med J (1986) 1.18
The search for new off-label indications for antidepressant, antianxiety, antipsychotic and anticonvulsant drugs. J Psychiatry Neurosci (2006) 1.13
On the significance of giant somatosensory evoked potentials in cortical myoclonus. J Neurol Neurosurg Psychiatry (1984) 1.05
Uraemic myoclonus: an example of reticular reflex myoclonus? J Neurol Neurosurg Psychiatry (1979) 0.92
Substance abuse and movement disorders: complex interactions and comorbidities. Curr Drug Abuse Rev (2012) 0.83
Somatosensory evoked potentials following stimulation of the lower limb in cortical reflex myoclonus. J Neurol Neurosurg Psychiatry (1987) 0.83
Treatment of myoclonus. Neurotherapeutics (2014) 0.79
Effect of dialysis on plasma and CSF tryptophan and CSF 5-hydroxyindoleacetic acid in advanced renal disease. J Neurol Neurosurg Psychiatry (1980) 0.77
Effect of milacemide on extracellular and tissue concentrations of dopamine and 5-hydroxytryptamine in rat frontal cortex. Br J Pharmacol (1992) 0.77
Effects of alcohol on myoclonus and somatosensory evoked potentials in dyssynergia cerebellaris myoclonica. J Neurol Neurosurg Psychiatry (1991) 0.75
Dopamine agonists suppress visual-cortical reflex myoclonus. J Neurol Neurosurg Psychiatry (1985) 0.75
Observations on chloralose-induced myoclonus in guinea-pigs. Br J Pharmacol (1980) 0.75
Functional independence in post-anoxic myoclonus: contribution of L-5-HTP sodium valproate and clonazepam. Br Med J (1978) 0.75
Cherry-red spot myoclonus syndrome and alpha-neuraminidase deficiency: neurophysiological, pharmacological and biochemical study in an adult. J Neurol Neurosurg Psychiatry (1980) 0.75
5-Hydroxytryptamine and myoclonus induced by 1,2-di-hydroxybenzene (catechol) in the guinea-pig. Br J Pharmacol (1979) 0.75
Somatosensory and acoustic brain stem reflex myoclonus. J Neurol Neurosurg Psychiatry (1988) 0.75
Reversible myoclonus with uraemia. Br Med J (Clin Res Ed) (1981) 0.75
Combined MEG-EEG source localisation in patients with sub-acute sclerosing pan-encephalitis. Neurol Sci (2016) 0.75
Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet (1980) 10.23
Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol (1994) 9.41
Corticocortical inhibition in human motor cortex. J Physiol (1993) 8.92
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology (1996) 8.82
Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst (1993) 6.02
Mitochondrial complex I deficiency in Parkinson's disease. Lancet (1989) 5.72
Electric and magnetic stimulation of human motor cortex: surface EMG and single motor unit responses. J Physiol (1989) 5.69
Rapid preparation of lymphocytes for tissue-typing. Lancet (1969) 5.11
Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology (1997) 4.93
Servo action in the human thumb. J Physiol (1976) 4.93
One drug for epilepsy. Br Med J (1978) 4.87
The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA (1999) 4.80
Interhemispheric inhibition of the human motor cortex. J Physiol (1992) 4.77
Clinical features and natural history of von Hippel-Lindau disease. Q J Med (1990) 4.71
International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci (1997) 4.50
Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol (1992) 4.48
Servo action in human voluntary movement. Nature (1972) 4.33
One drug (phenytoin) in the treatment of epilepsy. Lancet (1976) 4.32
Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem (1990) 4.03
Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet (1983) 4.02
Activation of the primary visual cortex by Braille reading in blind subjects. Nature (1996) 3.91
Cystic fibrosis carrier testing in early pregnancy by general practitioners. BMJ (1993) 3.85
Quantum annealing with manufactured spins. Nature (2011) 3.81
Chronic antiepileptic toxicity: a review. Epilepsia (1975) 3.70
Painful legs and moving toes. Brain (1971) 3.63
Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature (1992) 3.63
A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet (1992) 3.63
Videotape-based decision aid for colon cancer screening. A randomized, controlled trial. Ann Intern Med (2000) 3.61
Von Hippel-Lindau disease: a genetic study. J Med Genet (1991) 3.61
Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain (1994) 3.57
Validity and reliability of a rating scale for the primary torsion dystonias. Neurology (1985) 3.56
Reduction in polypharmacy for epilepsy. Br Med J (1979) 3.56
The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain (1994) 3.54
Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child (1981) 3.45
Writers' cramp-a focal dystonia. Brain (1982) 3.43
Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms. BMJ (1998) 3.41
Outcome of investigation of patients with presenile dementia. Br Med J (1972) 3.39
Informed choice in genetic screening for thalassaemia during pregnancy: audit from a national confidential inquiry. BMJ (2000) 3.38
Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet (2005) 3.38
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science (1990) 3.31
Stretch reflex and servo action in a variety of human muscles. J Physiol (1976) 3.29
Modulation of muscle responses evoked by transcranial magnetic stimulation during the acquisition of new fine motor skills. J Neurophysiol (1995) 3.27
Rapid plasticity of human cortical movement representation induced by practice. J Neurophysiol (1998) 3.26
Scope of a technique for electrical stimulation of human brain, spinal cord, and muscle. Lancet (1982) 3.26
The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture. Neurology (1982) 3.26
Monotherapy or polytherapy for epilepsy? Epilepsia (1981) 3.25
A clinical study of type 2 neurofibromatosis. Q J Med (1992) 3.23
Corticobasal degeneration. Brain (1989) 3.20
Stimulation of the human motor cortex through the scalp. Exp Physiol (1991) 3.16
A physiological mechanism of bradykinesia. Brain (1980) 3.15
Unnecessary polypharmacy for epilepsy. Br Med J (1977) 3.12
Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry (1997) 3.02
Peripheral beta-adrenergic receptors concerned with tremor. Clin Sci (1967) 2.97
Dose standardisation of botulinum toxin. Lancet (1989) 2.83
The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med (1980) 2.81
Motor cortex stimulation in intact man. 2. Multiple descending volleys. Brain (1987) 2.77
Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy. Ann Neurol (1995) 2.76
Classification of dystonia. Adv Neurol (1998) 2.75
Botulinum toxin in spasmodic torticollis. J Neurol Neurosurg Psychiatry (1988) 2.74
Enhancement of recovery from psychiatric illness by methylfolate. Lancet (1990) 2.73
Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). A variant of adult-onset torsion dystonia? J Neurol Neurosurg Psychiatry (1976) 2.72
EMG analysis of stereotyped voluntary movements in man. J Neurol Neurosurg Psychiatry (1975) 2.71
Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology (2004) 2.70
Apparent prevention of neural tube defects by periconceptional vitamin supplementation. 1981. Int J Epidemiol (2011) 2.68
Spinal motor neuron excitability during the silent period after cortical stimulation. Electroencephalogr Clin Neurophysiol (1991) 2.68
Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med (1997) 2.67
Human walking and higher-level gait disorders, particularly in the elderly. Neurology (1993) 2.65
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol (1994) 2.65
Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain (1992) 2.64
Manual motor performance in a deafferented man. Brain (1982) 2.63
Drug treatment of epilepsy. Lancet (1978) 2.63
Factors associated with the starting of cigarette smoking by primary school children. Br J Prev Soc Med (1974) 2.61
The anatomical basis of symptomatic hemidystonia. Brain (1985) 2.60
Is the human stretch reflex cortical rather than spinal? Lancet (1973) 2.58
"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet (1976) 2.54
Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry (2000) 2.53
Movement disorders in multiple sclerosis. Mov Disord (1995) 2.53
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain (1991) 2.52
The pathophysiology of primary dystonia. Brain (1998) 2.51
Pathophysiology of blepharospasm and oromandibular dystonia. Brain (1985) 2.50
Comparison of pregnancy outcome after amniocentesis for previous neural tube defect or raised maternal serum alphafetoprotein. Br J Obstet Gynaecol (1980) 2.50
A method of monitoring function in corticospinal pathways during scoliosis surgery with a note on motor conduction velocities. J Neurol Neurosurg Psychiatry (1986) 2.50
Uptake of presymptomatic predictive testing for Huntington's disease. Lancet (1989) 2.49
Tissue typing using a routine one-step lymphocyte separation procedure. Br J Haematol (1970) 2.48
Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry (1988) 2.46
Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol (1990) 2.45
Changes in the response to magnetic and electrical stimulation of the motor cortex following muscle stretch in man. J Physiol (1991) 2.44
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem (1989) 2.44
Effects of folic acid on the mental state and fit-frequency of drug-treated epileptic patients. Lancet (1967) 2.42